Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2025-12-24 @ 6:47 PM
NCT ID:
NCT00959257
Eligibility Criteria:
Inclusion Criteria:
* Adult Chinese asthma patients
* Stable persistent asthma who are current inhaled corticosteroid users OR
* Healthy controls will be non inhaled corticosteroid users matched for age, gender and BMI from the Hong Kong Cardiovascular Risk Factor Prevalence Study II (CRISPSII) carried out on a random population sample in Hong Kong
Exclusion Criteria:
* On maintenance oral steroid
* Systemic steroid use in recent 6 months
* Asthma exacerbation (GINA criteria) in recent 1 month (ie daytime or nocturnal symptoms increment, detectable wheezing on physical examination, drop in peak flow rate, drop in spirometry indexes, increase in asthma medication, emergency medical attendance for asthma, days off work for asthma etc)
* Inhaled corticosteroid use for \< 6 months
* Pregnancy
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
35 Years
Maximum Age:
74 Years
Study:
NCT00959257
Study Brief:
Protocol Section:
NCT00959257